{"count": 4, "results": [{"_id": "7073794", "pmid": 7073794, "title": "Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits.", "journal": "Atherosclerosis", "authors": ["Tremoli E", "Ghiselli G", "Maderna P", "Colli S", "Sirtori CR"], "date": "1982-01-01T00:00:00Z", "doi": "10.1016/0021-9150(82)90069-7", "meta_date_publication": "1982 Jan", "meta_volume": "41", "meta_issue": "1", "meta_pages": "53-60", "score": 50072.312, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ reduces @DISEASE_Drug_Hypersensitivity @DISEASE_MESH:D004342 @@@platelet hypersensitivity@@@ in @<m>DISEASE_Hyperlipoproteinemia_Type_II</m> @DISEASE_MESH:D006938 @@@hypercholesterolemic@@@ @SPECIES_9986 @@@rabbits@@@.", "citations": {"NLM": "Tremoli E, Ghiselli G, Maderna P, Colli S, Sirtori CR. Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits. Atherosclerosis. 1982 Jan;41(1):53-60. PMID: 7073794", "BibTeX": "@article{7073794, title={Metformin reduces platelet hypersensitivity in hypercholesterolemic rabbits.}, author={Tremoli E and Ghiselli G and Maderna P and Colli S and Sirtori CR}, journal={Atherosclerosis}, volume={41}, number={1}, pages={53-60}}"}}, {"_id": "7259886", "pmid": 7259886, "title": "[Inhibitory effect of metformin on the development of cholesterol atherosclerosis in the rabbit. Observations on the coronary vessels].", "journal": "Boll Soc Ital Biol Sper", "authors": ["Giacchi M", "Vatti R"], "date": "1981-03-15T00:00:00Z", "meta_date_publication": "1981 Mar 15", "meta_volume": "57", "meta_issue": "5", "meta_pages": "552-5", "score": 50063.43, "text_hl": "The @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerotic lesions@@@ which are always present in the coronary arteries of the @<m>DISEASE_Hyperlipoproteinemia_Type_II</m> @DISEASE_MESH:D006938 @@@hypercholesterolemic@@@ @SPECIES_9986 @@@rabbits@@@ are not evident in the coronaries (at extra- as well at intracardiac level) of the @<m>DISEASE_Hyperlipoproteinemia_Type_II</m> @DISEASE_MESH:D006938 @@@hypercholesterolemic@@@ @SPECIES_9986 @@@rabbits@@@ treated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Giacchi M, Vatti R. [Inhibitory effect of metformin on the development of cholesterol atherosclerosis in the rabbit. Observations on the coronary vessels]. Boll Soc Ital Biol Sper. 1981 Mar 15;57(5):552-5. PMID: 7259886", "BibTeX": "@article{7259886, title={[Inhibitory effect of metformin on the development of cholesterol atherosclerosis in the rabbit. Observations on the coronary vessels].}, author={Giacchi M and Vatti R}, journal={Boll Soc Ital Biol Sper}, volume={57}, number={5}, pages={552-5}}"}}, {"_id": "18421184", "pmid": 18421184, "title": "Metformin and parameters of physical health.", "journal": "Intern Med", "authors": ["Helvaci MR", "Kaya H", "Borazan A", "Ozer C", "Seyhanli M", "Yalcin A"], "date": "2008-01-01T00:00:00Z", "doi": "10.2169/internalmedicine.47.0787", "meta_date_publication": "2008", "meta_volume": "47", "meta_issue": "8", "meta_pages": "697-703", "score": 50060.477, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and parameters of physical health.", "citations": {"NLM": "Helvaci MR, Kaya H, Borazan A, Ozer C, Seyhanli M, Yalcin A. Metformin and parameters of physical health. Intern Med. 2008;47(8):697-703. PMID: 18421184", "BibTeX": "@article{18421184, title={Metformin and parameters of physical health.}, author={Helvaci MR and Kaya H and Borazan A and Ozer C and Seyhanli M and Yalcin A}, journal={Intern Med}, volume={47}, number={8}, pages={697-703}}"}}, {"_id": "26146893", "pmid": 26146893, "title": "The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.", "journal": "Cardiovasc Ther", "authors": ["Krysiak R", "Gilowski W", "Szkrobka W", "Okopien B"], "date": "2015-10-01T00:00:00Z", "doi": "10.1111/1755-5922.12143", "meta_date_publication": "2015 Oct", "meta_volume": "33", "meta_issue": "5", "meta_pages": "282-7", "score": 50043.48, "text_hl": "CONCLUSIONS: The obtained results suggest that the effect of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ on plasma @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipids@@@ and circulating levels of cardiometabolic risk factors does not differ between @SPECIES_9606 @@@patients@@@ receiving @CHEMICAL_Bromocriptine @CHEMICAL_MESH:D001971 @@@bromocriptine@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@. @CHEMICAL_Bromocriptine @CHEMICAL_MESH:D001971 @@@Bromocriptine@@@-statin combination therapy may be an alternative to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@-statin combination therapy in @<m>DISEASE_Hyperlipoproteinemia_Type_II</m> @DISEASE_MESH:D006938 @@@hypercholesterolemic@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Glucose_Metabolism_Disorders @DISEASE_MESH:D044882 @@@glucose metabolism abnormalities@@@ in whom @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ administration is either contraindicated or results in adverse effects.", "citations": {"NLM": "Krysiak R, Gilowski W, Szkrobka W, Okopien B. The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia. Cardiovasc Ther. 2015 Oct;33(5):282-7. PMID: 26146893", "BibTeX": "@article{26146893, title={The Effect of Atorvastatin on Cardiometabolic Risk Factors in Bromocriptine-Treated Premenopausal Women with Isolated Hypercholesterolemia.}, author={Krysiak R and Gilowski W and Szkrobka W and Okopien B}, journal={Cardiovasc Ther}, volume={33}, number={5}, pages={282-7}}"}}]}